Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients
| Data(s) |
01/11/2013
|
|---|---|
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/44105/1/de%20viragh_j%20am%20acad%20dermatol.pdf Spring, Philipp; Spanou, Zoi; de Viragh, Pierre A. (2013). Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients. Journal of the American Academy of Dermatology, 69(5), pp. 830-832. Elsevier 10.1016/j.jaad.2013.04.066 <http://dx.doi.org/10.1016/j.jaad.2013.04.066> doi:10.7892/boris.44105 info:doi:10.1016/j.jaad.2013.04.066 info:pmid:24124823 urn:issn:0190-9622 |
| Idioma(s) |
eng |
| Publicador |
Elsevier |
| Relação |
http://boris.unibe.ch/44105/ |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Spring, Philipp; Spanou, Zoi; de Viragh, Pierre A. (2013). Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients. Journal of the American Academy of Dermatology, 69(5), pp. 830-832. Elsevier 10.1016/j.jaad.2013.04.066 <http://dx.doi.org/10.1016/j.jaad.2013.04.066> |
| Palavras-Chave | #610 Medicine & health |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |
